Archipel Asset Management’s Gilead Sciences GILD Stock Holding History

Archipel Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.52M	Buy	+33,057	New	+$3.24M	1.02%	38

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Archipel Asset Management's GILD Position: Q3 2014 in Review

Archipel Asset Management opened a new position in Gilead Sciences (GILD) in Q3 2014: 33,057 shares worth $3.52M. The stake represents 1.02% of the portfolio and ranks #38 among its holdings.

1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

Archipel Asset Management held 33,057 shares of Gilead Sciences worth $3.52M as of Q3 2014.
Gilead Sciences was a new Archipel Asset Management position in Q3 2014.
Gilead Sciences made up 1.02% of Archipel Asset Management's portfolio in Q3 2014, its #38 holding.
1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Archipel Asset Management's 13F filing for Q3 2014, filed 15 Oct 2014.